Skip to content
Screener
Medtronic logo

Medtronic

MDT

Medtronic is a global leader in healthcare technology that researches, designs, manufactures, and sells device-based medical therapies and services.

Market cap
$112.24B-8.2%
Revenue$37.5B+9.8%
Net income$5.2B+12.3%
Free cash flow$6.1B+15.6%
EPS (diluted)$4.07+12.1%
Trailing twelve months · change vs. prior year

Earnings

Next report

Nov 17, 2026 (in a month)
Revenue estimate$9.5B
EPS estimate$1.34

Financials

Q1 2027

Income statement

See full
Revenue$9.8B+13.7%
Gross profit$6.3B+13.7%
Operating income$1.8B+22.1%
Net income$1.5B+41.3%
EPS (diluted)$1.14+40.7%

Balance sheet

See full
Cash & equivalents$1.7B+32.8%
Total debt$28.2B-1.6%
Total equity$50.2B+4.9%
Total assets$93.3B+2.6%

Cash flow

See full
Operating cash flow$1.8B+64.8%
CapEx$503.0M-0.2%
Free cash flow$1.3B+121%

Valuation & ratios

Valuation

See full
Market cap$112.24B-8.2%
Enterprise value$138.76B-8.2%
P/E21.5×-5.1×
P/S3×-0.6×

Profitability

See full
Gross margin65%-0.3pp
Operating margin18.1%+0.2pp
Net margin13.9%+0.3pp
FCF margin16.3%+0.8pp

Returns & leverage

See full
Return on equity10.7%+0.9pp
Debt / equity0.6×0.0×
Current ratio2.1×+0.1×

Segments

By segment

See full
Cardiovascular$3.9B+19.5%
Neuroscience$2.7B+10.3%
Medical Surgical$2.3B+9.9%
Diabetes$843.0M+16.9%
Other operating segment, misc$29.0M—

Competitors

Profile

Medtronic is a global leader in healthcare technology that researches, designs, manufactures, and sells device-based medical therapies and services. The company focuses on alleviating pain and restoring health through biomedical engineering, integrating artificial intelligence and data analytics to personalize patient care. It operates a vast distribution network serving healthcare systems and physicians in more than 150 countries.

Competitive position

A leading global healthcare technology company characterized by a massive R&D pipeline and a dominant presence in cardiovascular and surgical robotics markets.

GeographiesUnited States, Western Europe, China, Japan, Ireland
Customer segmentsHospitals, Physicians, Group Purchasing Organizations (GPOs), Integrated Delivery Networks (IDNs)
Business modelManufacturing, Direct Sales, Consignment Inventory, Service and Support
SuppliersSpecialized component manufacturers, Raw material suppliers, Third-party R&D funding partners
CustomersHospitals, Ambulatory surgical centers, Long-term care facilities, Home care patients
CountryIreland
Listed1972
Employees95.0K
CEOGeoffrey Straub Martha
FilingsSEC EDGAR

FAQ

What is Medtronic's market cap?
Medtronic (MDT) has a market capitalization of $112.24B and trades on NYSE.
What is Medtronic's revenue and profitability?
Medtronic generated $37.5B in trailing twelve-month revenue with net income of $5.2B, representing a net margin of 13.9%. Gross margin stands at 65.0%, with free cash flow of $6.1B. The latest reported period is Q1 2027.
Who are Medtronic's competitors?
Medtronic's key competitors include Stryker Corporation, Boston Scientific, Abbott Laboratories, and others. These companies compete in similar markets and product categories.
What subsidiaries does Medtronic have?
Medtronic's subsidiaries include Mazor Robotics, Affera.
Where is Medtronic headquartered?
Medtronic is headquartered in Ireland and employs approximately 95,000 people. It has been publicly traded since 1972.